Incyte Corporation - Common Stock (INCY)
Industrials › Services-Commercial Physical & Biological Research
Price History
Feb 9, 2026 — May 9, 2026Investment Snapshot
- Trading 54% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 5/9 — moderate financial health
- Strong ROE of 23.0% with 26.3% net margin
- Revenue growing at 21% annually
Incyte Corporation - Common Stock (INCY) is a Industrials company operating in Services-Commercial Physical & Biological Research, listed on the NASDAQ , with a market capitalisation of $19.7 billion . Key value metrics: P/E ratio 15.3, P/B ratio 3.50, Piotroski F-Score 5 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Incyte Corporation - Common Stock — Fundamental Analysis Summary
Incyte Corporation - Common Stock (INCY) is currently trading 54% above its Graham Number of $63.96, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries a reasonable trailing P/E ratio of 15.3x.
On financial health, INCY shows a moderate Piotroski F-Score of 5/9, and strong return on equity of 23.0% (sector average: 4.9%), and manageable leverage with a debt-to-equity ratio of 0.35.
StockPik's composite Value Score for INCY is 91/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
INCY reports a high gross margin of 92.8% (sector average: 46.3%) and a strong operating margin of 30.2%.
INCY shows revenue growing at 21% year-over-year, with earnings growing at 3,845%.